Differences in the Control of Secondary Peristalsis in the Human Esophagus: Influence of the 5-HT4 Receptor versus the TRPV1 Receptor by Chih-Hsun Yi et al.
RESEARCH ARTICLE
Differences in the Control of Secondary
Peristalsis in the Human Esophagus:
Influence of the 5-HT4 Receptor versus the
TRPV1 Receptor
Chih-Hsun Yi1, Wei-Yi Lei1, Jui-Sheng Hung1, Tso-Tsai Liu1, William C. Orr2, Pace Fabio3,
Chien-Lin Chen1*
1 Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi
University, Hualien, Taiwan, 2 Lynn Institute for Healthcare Research, University of Oklahoma Health
Sciences Center, Oklahoma City, OK, United States of America, 3 Division of Gastroenterology, Department




Acute administration of 5-hydroxytryptamine4 (5-HT4) receptor agonist, mosapride or
esophageal infusion of the transient receptor potential vanilloid receptor-1 (TRPV1) agonist
capsaicin promotes secondary peristalsis. We aimed to investigate whether acute esoph-
ageal instillation of capsaicin-containing red pepper sauce or administration of mosapride
has different effects on the physiological characteristics of secondary peristalsis.
Methods
Secondary peristalsis was induced with mid-esophageal air injections in 14 healthy sub-
jects. We compared the effects on secondary peristalsis subsequent to capsaicin-contain-
ing red pepper sauce (pure capsaicin, 0.84 mg) or 40 mg oral mosapride.
Results
The threshold volume for generating secondary peristalsis during slow air distensions was
significantly decreased with capsaicin infusion compared to mosapride (11.6 ± 1.0 vs. 14.1
± 0.8 mL, P = 0.02). The threshold volume required to produce secondary peristalsis during
rapid air distension was also significantly decreased with capsaicin infusion (4.6 ± 0.5 vs.
5.2 ± 0.6 mL, P = 0.02). Secondary peristalsis was noted more frequently in response to
rapid air distension after capsaicin infusion than mosapride (80% [60–100%] vs. 65% [5–
100%], P = 0.04). Infusion of capsaicin or mosapride administration didn’t change any
parameters of primary or secondary peristalsis.
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Conclusions
Esophageal infusion with capsaicin-containing red pepper sauce suspension does create
greater mechanosensitivity as measured by secondary peristalsis than 5-HT4 receptor ago-
nist mosapride. Capsaicin-sensitive afferents appear to be more involved in the sensory
modulation of distension-induced secondary peristalsis.
Introduction
Primary peristalsis is initiated by a swallow and is the main source of esophageal transit
whereas distension-induced or secondary peristalsis functions to maintain an empty esophagus
by clearing refluxate from the stomach [1] in the absence of swallowing. Distension-induced
secondary peristalsis has been extensively studied regarding its physiological characteristics
and clinical applications in a variety of esophageal symptoms and disorders such as non-
obstructive dysphagia and gastroesophageal reflux disease (GERD) [2–6]. Secondary peristalsis
can be physiologically triggered by different intraesophageal stimuli including air, mechanical
distention, or water infusion [4]. The control of secondary peristalsis in the striated muscle is
modulated by central mechanisms with vagal afferents, which subsequently results in sequen-
tial vagal efferent discharge to the striated musculature of the proximal esophagus [7], while
secondary peristalsis in the smooth muscle part is controlled by an intrinsic neuromuscular
reflex. Specifically, the intrinsic reflex that modulates secondary peristalsis includes mucosal
and intramuscular mechanoreceptors which contribute to initiate and propagate peristalsis
[8, 9].
Several types of acid—sensitive ion channels of the esophagus are demonstrated in sensory
afferent neurons including acid sensing ion channels, acid-sensitive tandem-pore channels,
transient receptor potential cation channels (TRP channels), and ionotrophic purinoreceptor
channels [10] Capsaicin as well as acid pH can stimulate the transient receptor potential vanil-
loid receptor 1 (TRPV1) to mediate heartburn sensation [11] and modulate gastrointestinal
motility [12, 13]. Previous studies have demonstrated that secondary peristaltic activity and
distension sensitivity can be enhanced by esophageal infusion with capsaicin-containing red
pepper sauce [14]. Subsequent work has shown that continued exposure of the esophagus to
capsaicin infusion is characterized by the activation of TRPV1 receptors and then desensitiza-
tion of secondary peristalsis [15].
Mosapride, a prokinetic agent, stimulates gastrointestinal motility by facilitating the release
of acetylcholine from postganglionic nerve endings of the myenteric plexus via 5-hydroxytryp-
tamine4 (5-HT4) receptors [16]. It has been shown to elevate resting lower esophageal sphinc-
ter (LES) pressure [17], and improve esophageal peristaltic function in patients with GERD
[18]. In addition, mosapride is further shown to improve esophageal bolus transit in healthy
volunteers [19]. Recently, we have shown that mosapride enhances mechanosensitivity to dis-
tension-induced secondary peristalsis and facilitates secondary peristaltic contractility, suggest-
ing that the 5-HT4 receptors may participate in the modulation of secondary peristalsis [20].
Given the well-established data showing that both capsaicin-containing red pepper sauce
and 5-HT4 receptor agonist mosapride can enhance esophageal distension threshold and rele-
vant esophageal contractility [14, 20], it is yet to be determined whether those agents have dif-
ferential effects on secondary esophageal peristalsis. The aim of this study was to investigate
the hypothesis that acute application of capsaicin-containing red pepper sauce or the 5-HT4
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receptor agonist mosapride may have different physiological effects on esophageal secondary
peristalsis as induced by slow and rapid air injections.
Materials and Methods
Subjects
Fourteen healthy adults (5 women, mean age 22, range 19–26 years) were enrolled into this
study by university advertisement. None of them had any esophageal symptoms, or a history of
gastrointestinal disease, or drug allergies. None were taking prokinetic medications or reported
frequent consumption of red chili pepper. Written informed consent was obtained from each
subject and the study was approved by the Ethics Committee of Hualien Tzu Chi Hospital,
Taiwan.
Esophageal manometry
Recordings of intraluminal pressures were made using a Koenigsberg 4-channel 4.5-mm solid-
state probe (Sandhill Scientific, Inc., Highlands Ranch, CO, USA) incorporated with one cir-
cumferential pressure sensor at 5 cm and three unidirectional pressure sensors at 10, 20, and
25 cm from the tip. The infusion port was in the mid esophagus with its location between 15
and 20 cm from the tip. After an overnight fast, each subject had the catheter passed through
the nose in the supine position into the esophagus. By using stationary pull-through technique,
the catheter was finally placed with its most distal sensor in the high-pressure zone of the LES.
Recordings of intraluminal pressures were continuously stored on the computer for subsequent
analysis. We detected swallowing events by the most proximal channel of the catheter, which
was located in the pharynx in order to differentiate primary and secondary peristalses.
Study design
Primary and secondary peristalsis were compared 10 minutes (min) after the infusion of capsa-
icin-containing red pepper sauce (pure capsaicin, 0.84 mg) or 60 min after oral mosapride (40
mg) [21]. Subjects were studied on two occasions at least 1-week apart. The test capsaicin solu-
tion contained 5 mL of red pepper sauce (Tabasco, McIIhenny Company, Avery Island, LA,
USA), diluted with 15 mL of saline, which was infused into the mid esophagus via the mano-
metric catheter at a rate of 10 mL/min. The capsaicin dose was based on prior study on second-
ary peristaslsis in which the total amount of pure capsaicin included in the infused red pepper
sauce suspension (5 mL of Tabasco) was equivalent to 0.84 mg of pure capsaicin [13, 14]. The
dose of oral mosapride was chosen according to our previous work on secondary peristalsis
[20].
Primary peristalsis was tested with ten, 5 mL normal saline swallows. Each swallow was sep-
arated by an interval of 20 seconds (sec). Secondary peristalsis was evoked by direct esophagus
injection of air accomplished first by a slow air (0.25 mL/sec) via an automatic infusion pump
attached to the manometry catheter. The amount of total volume tested was determined
according to the rate and time for injection of air for triggering secondary peristalsis. Secondary
peristalsis was then triggered with rapid air injection by hand, in which we started at 1-mL vol-
ume and gradually increased the volume at 1-mL increments until the response of a secondary
peristalsis was seen or injected volume reached 20 mL without a positive response. We deter-
mined the threshold volumes for slow and rapid air injections as the lowest injection volume
that triggered a secondary peristalsis [22]. Then, ten 20-mL air was injected within 0.5 sec to
assess secondary peristaltic response and manometric parameters. Successful response was rec-
ognized within a period of 20 sec, during which each subject was instructed not to swallow. At
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the end of the 20 sec period, each subject was asked to perform a dry swallow that helped clear
any residual air before the next stimulus and reduce the desire to swallow.
Data analysis
Complete primary peristalsis was identified when the pressure wave in the proximal esophagus
was greater than 12 mmHg and that in the distal esophagus was greater than 25 mmHg with
normal propagation [4]. Peristaltic progression was defined when the minimal latency of wave
onset was 0.5 sec between two recording channels. Failed peristalsis was noted when there was
a lack of a pressure wave, ≧ 12 mmHg in the proximal esophagus or ≧ 25 mmHg in the distal
esophagus, or occurrence of synchronous pressure waves. Secondary peristalsis was determined
to be complete according to the criteria given for primary peristalsis [4]. Data for esophageal
wave amplitude (mmHg) and duration (sec) of secondary peristalsis were recorded and com-
pared for the distal esophagus.
Statistical analysis
The frequencies of successful primary and secondary peristalsis were determined in each sub-
ject as a percentage of the number for each stimulus. Differences in the frequencies were
expressed as median with interquartile range in parentheses and compared using the Wilcoxon
signed-rank test. All other data including threshold volumes, peristaltic wave amplitudes, and
contractile duration were expressed with mean ± SEM and compared with a paired t-test
between capsaicin infusion and oral administration of mosapride. Differences were considered
statistically significant when a P-value of< 0.05. Statistical analyses were performed with SPSS
19 for Windows (SPSS, Inc, IL, USA).
Results
Comparison of esophageal distension threshold between capsaicin
infusion and mosapride administration
The threshold volume for triggering secondary peristalsis during slow air injection was signifi-
cantly decreased with capsaicin infusion compared to mosapride (11.6 ± 1.0 vs. 14.1 ± 0.8 mL,
P = 0.02) (Fig 1). Similarly, the threshold volume for generating secondary peristalsis during
rapid air injection was significantly decreased with capsaicin infusion (4.6 ± 0.5 vs. 5.2 ± 0.6
mL, P = 0.02) (Fig 1). Secondary peristalsis was detected more frequently in response to rapid
air injection with capsaicin infusion compared to mosapride (80% [60–100%] vs. 65% [50–
100%], P = 0.04) (Fig 2).
Comparison of primary and secondary peristaltic activity between
capsaicin infusion and mosapride administration
Table 1 summarizes the results for primary peristalsis between capsaicin infusion and oral
administration of mosapride. No significant difference was found in any of the primary peri-
staltic parameters or LES pressure between capsaicin infusion and use of mosapride (Table 1).
The frequency of primary peristalsis was above 90% for both capsaicin infusion and mosapride
(Table 1). There was also no difference in pressure wave amplitude or peristaltic duration dur-
ing slow or rapid air injection between capsaicin infusion and mosapride (Table 2).
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Fig 1. A The threshold volume for triggering secondary peristalsis during slow air injection is
significantly lower with capsaicin infusion than oral administration of mosapride (11.6 ± 1.0 vs.
14.1 ± 0.8 mL, *P = 0.02); B the threshold volume for generating secondary peristalsis during rapid air
injection is significantly lower with capsaicin infusion than oral administration of mosapride (4.6 ± 0.5
vs. 5.2 ± 0.6 mL, *P = 0.02). Values are expressed as mean ± SEM. Line represents the mean value.
doi:10.1371/journal.pone.0159452.g001
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Discussion
The important finding from this study is that the infusion of capsaicin-containing red pepper
sauce directly into mid-esophagus enhances greater esophageal mechanosensitivity stimulating
secondary peristalsis and facilitating more secondary peristaltic activities in response to rapid
esophageal distension when compared to oral administration of mosapride. These findings are
in line with previous works done in humans which documented the presence of prokinetic
effects on primary and secondary peristalsis subsequent to capsaicin infusion [14] and the
administration of the 5-HT4 agonist mosapride [20].
In an early study [20], the 5-HT4 agonist mosapride administration was shown to improve
contractility in the esophageal smooth muscle with primary peristalsis. In addition, oral admin-
istration of mosapride also promoted secondary peristalsis by enhancing esophageal mechano-
sensitivity of distension-induced secondary peristalsis along with improving the frequency of
Fig 2. Secondary peristalsis is triggedmore frequently in response to rapid air injection with
capsaicin infusion than oral administration of mosapride (80% [60–100%] vs. 65% [50–100%],
*P = 0.04). Values are expressed as median with interquartile range.
doi:10.1371/journal.pone.0159452.g002
Table 1. Effect of mosapride and capsaicin onmanometric parameters of primary peristalsis.
Mosapride Capsaicin P-value
Amplitude of contractions (mmHg)
Proximal 43.7 (4.8) 42.8 (6.2) 0.8
Middle 80.4 (6.5) 79.9 (8.1) 0.88
Distal 98.6 (8.6) 101.1 (7.5) 0.67
Duration of contractions (sec)
Proximal 2.3 (0.1) 2.3 (0.1) 0.4
Middle 2.3 (0.1) 2.3 (0.1) 0.71
Distal 2.6 (0.2) 2.6 (0.1) 0.98
LES pressure (mmHg)
Fc Basal 24.0 (3.0) 25.0 (1.9) 0.73
Residual 0.4 (1.3) 1.9 (1.3) 0.23
Complete peristalsis (%) 90 92 0.57
Values are means (SE) or percentage.
doi:10.1371/journal.pone.0159452.t001
Mosapride versus Capsaicin on Secondary Peristalsis
PLOS ONE | DOI:10.1371/journal.pone.0159452 July 20, 2016 6 / 11
complete secondary peristalsis as induced by rapid distension of the esophagus [20]. However,
besides its prokinetic effect on motor activity of secondary peristalsis, the influence of the
5-HT4 agonist mosapride on sensory modulation of secondary peristalsis appears to be more
specific to rapid air distension of the esophagus [20]. Of interest is that similar physiological
phenomena have been observed with esophageal infusion with capsaicin-containing red pep-
per sauce [14], in which capsaicin infusion not only improved primary peristalsis but also sec-
ondary peristalsis in response to both slow and rapid distension of the esophagus. Since the
response to rapid air distension is mediated by mechanoreceptors of esophageal mucosa and
that to slow air distension is mediated by those of the esophageal muscularis [9, 23–25], it
appears that capsaicin may play a broader role in the modulation of distension-induced sec-
ondary peristalsis than oral administration of mosapride. Therefore, based on our findings, it is
conceivable that the infusion of capsaicin-containing red pepper sauce is more effective than
mosapride regarding the ability to stimulate secondary peristalsis.
The mechanism through which capsaicin infusion could increase secondary peristaltic
activity is mainly by altering membrane permeability to Ca2+ in primary afferent neurons [26]
with consequent release of numerous stimulatory neuropeptides [27]. Previous studies failed to
demonstrate any motor response as induced by capsaicin infusion in patients with severe
mucosa injury of the esophagus such as Barrett’s esophagus [28]. This suggests that the integ-
rity of sensory afferent modulation of esophageal peristalsis is important to achieve physiologi-
cal effectiveness of esophageal motility. When compared with the mechanism of capsaicin
infusion on esophageal peristalsis, the 5-HT4 agonist mosapride appears to provoke the activa-
tion of normal peristaltic reflex by enhancing the release of neurotransmitters from mucosally
activated submucosal intrinsic primary afferents, which is crucial for its prokinetic effects on
esophageal motility [29]. Specifically, the mechanism for its role in promoting esophageal peri-
stalsis is due to the fact that mosapride is reported to act through the release of acetylcholine
from postganglionic nerve endings of the myenteric plexus within gastrointestinal smooth
muscles [30]. The increase in motor activity is probably due to 5-HT4 receptors located on the
nerve terminals on myenteric ganglia [31].
Table 2. Effect of mosapride and capsaicin onmanometric parameters of secondary peristalsis.
Protocol Mosapride Capsaicin P-value
Slow injection
Peristaltic wave (mmHg)
Eso-m 66.1 (10.0) 65.2 (8.9) 0.64
Eso-d 94.6 (12.8) 87.7 (9.9) 0.66
Duration (sec)
Eso-m 2.7 (0.3) 3.0 (0.7) 0.95
Eso-d 3.0 (0.4) 3.5 (0.8) 0.64
Rapid injection
Peristaltic wave (mmHg)
Eso-m 71.2 (8.5) 73.8 (9.0) 0.72
Eso-d 93.7 (10.8) 102.0 (9.3) 0.35
Duration (sec)
Eso-m 2.4 (0.1) 2.8 (0.2) 0.12
Eso-d 2.8 (0.2) 3.3 (0.2) 0.29
Values are means (SE). Eso-m = mid-esophagus. Eso-d = distal esophagus.
doi:10.1371/journal.pone.0159452.t002
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We found that capsaicin infusion is more effective than mosapride in sensitizing distension
thresholds of secondary peristalsis as triggered by both direct slow and rapid injections of air
into the esophagus. Earlier studies have shown that capsaicin has differential effects on esoph-
ageal mechanoreceptors [32] with more influence on mucosal rather than muscular mechano-
receptors [33]. This is further supported by other works with repeated esophageal capsaicin
infusion in that selective attenuation of secondary peristalsis occurred predominantly with
rapid distension, i.e. via rapidly adapting mucosal mechanoreceptors [9], suggesting that dis-
tension-induced reflex can be mediated by different type of esophageal mechanoreceptors.
However, our prior work demonstrated that secondary peristalsis as induced by slow and rapid
air injections can be similarly influenced by capsaicin infusion. Moreover, repeated capsaicin
infusion also non-selectively desensitized distension thresholds of secondary peristalsis as
induced by slow and rapid air injections after esophageal pretreatment with capsaicin [15]. In
contrast, the effect of mosapride on secondary peristalsis only occurred with rapid air injec-
tions [20]. These finding may explain why capsaicin infusion appears to be more effective than
mosapride in sensory modulation of secondary peristalsis. In addition, it is possible that a cen-
tral control mechanism may play a role for modulating secondary peristalsis in intact human
esophagus when interacting with 5-HT4 or TRPV1 receptors [34].
In the present study, there were no differences in any of the secondary peristaltic wave
amplitudes between capsaicin infusion and mosapride administration, although prior works
have shown that both capsaicin infusion and mosapride significantly increased esophageal
wave amplitudes of secondary peristalsis [14, 20]. These data suggest that either direct stimula-
tion of mucosal mechanoreceptors or the activation of 5 HT4 receptors may similarly activate a
reflex mechanism which has been shown to enhance peristaltic amplitude [14, 20]. It is con-
ceivable that while capsaicin [35] stimulates activate C-fiber sensory afferents and consequently
enhances esophageal contractility, blood supply, and mucosa integrity by releasing numerous
neurotransmitters as well as generating distension-induced reflex [36], mosapride also induces
the release of acetylcholine from cholinergic nerve endings and stimulate esophageal motility
activity such as secondary peristalsis [20].
There are some clinical implications from these data. It is well established that mosapride
helps improve esophageal mechanosensitivity of distension-induced secondary peristalsis and
5-HT4 receptors are likely mediators of this response [20] However, current work suggests that
capsaicin-containing red pepper sauce creates more potent “prokinetic” influence in the modu-
lation of esophageal reflex in the response to different type of esophageal stimuli in terms of
promoting peristaltic efficiency. Furthermore, these findings also extend our prior notion that
although esophageal secondary peristalsis triggered by slow and rapid esophageal distension is
modulated by TRPV1 and 5-HT4 receptors, the novel evidence is that TRPV1 receptors appear
to be physiologically more active in mediating sensory modulation of esophageal secondary
peristalsis than 5-HT4 receptors during esophageal distension.
The present study therefore has some limitations regarding technique aspects which need to
be addressed. First, although the dose we have used in this work is able to successfully induce
sensitization in vivo effect of capsaicin in order to compare prokinetic effect of 5-HT4 agonist
mosapride regarding their influences on reflex induced secondary peristalsis it is unknown
whether the dosage of either application may have an equivalent effect on mediating the modu-
lation of secondary peristalsis [14, 20]. It may be argued that we didn’t apply median-effective
dose or maximum-effective dose, which could be more accurate than what we used in this
work. However, in human studies it is somewhat difficult to perform the experiment by using
median-effective dose or maximum-effective dose because of potential side/adverse effects that
may occur with maximum-effective dose such as capsaicin or mosapride. Finally, the data were
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obtained using conventional manometry which may be less comprehensive and informative
when compared with high resolution manometry [37].
Conclusions
In conclusion, we confirm the hypothesis that acute administration of capsaicin-containing red
pepper sauce suspension does create greater mechanosensitivity in response to slow and rapid
distension-induced esophageal reflex (i.e. secondary peristalsis) compared to the 5-HT4 recep-
tor agonist mosapride. This study provides additional physiological evidence that in the
human esophagus there is evidence for a differential contribution of TRPV1 and 5-HT4 recep-
tors which mediate the sensory modulation of secondary peristalsis. Capsaicin-sensitive affer-
ents appear to be more involved in sensory control of distension-induced secondary peristalsis
in human esophagus, while the motility aspects of secondary peristalsis are equally mediated
by both types of receptors.
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